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Abstract
Background: Recent advances in single-cell techniques have provided the opportunity to finely dissect cellular
heterogeneity within populations previously defined by “bulk” assays and to uncover rare cell types. In human
hematopoiesis, megakaryocytes and erythroid cells differentiate from a shared precursor, the megakaryocyte-erythroid
progenitor (MEP), which remains poorly defined.
Results: To clarify the cellular pathway in erythro-megakaryocyte differentiation, we correlate the surface
immunophenotype, transcriptional profile, and differentiation potential of individual MEP cells. Highly purified,
single MEP cells were analyzed using index fluorescence-activated cell sorting and parallel targeted transcriptional
profiling of the same cells was performed using a specifically designed panel of genes. Differentiation potential was
tested in novel, single-cell differentiation assays. Our results demonstrate that immunophenotypic MEP comprise three
distinct subpopulations: “Pre-MEP,” enriched for erythroid/megakaryocyte progenitors but with residual myeloid
differentiation capacity; “E-MEP,” strongly biased towards erythroid differentiation; and “MK-MEP,” a previously
undescribed, rare population of cells that are bipotent but primarily generate megakaryocytic progeny. Therefore,
conventionally defined MEP are a mixed population, as a minority give rise to mixed-lineage colonies while the
majority of cells are transcriptionally primed to generate exclusively single-lineage output.
Conclusions: Our study clarifies the cellular hierarchy in human megakaryocyte/erythroid lineage commitment and
highlights the importance of using a combination of single-cell approaches to dissect cellular heterogeneity and
identify rare cell types within a population. We present a novel immunophenotyping strategy that enables the
prospective identification of specific intermediate progenitor populations in erythro-megakaryopoiesis,
allowing for in-depth study of disorders including inherited cytopenias, myeloproliferative disorders, and
erythromegakaryocytic leukemias.
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Background
Hematopoietic stem cells (HSC) give rise to blood cells
of multiple lineages through step-wise lineage restriction
and the production of intermediate oligo- and bipotent
progenitors. In the traditional hierarchical model, HSC
sequentially differentiate into multipotent progenitors
(MPP) then common lymphoid progenitors (CLP) and
myeloid progenitors (CMP), the latter of which give rise
to granulocyte-macrophage progenitors (GMP) and
megakaryocyte-erythroid progenitors (MEP), which in
turn bifurcate to lineage-committed erythroid cells and
platelet-producing megakaryocytes [1, 2]. The cellular
populations in the HSC/progenitor hierarchy are distin-
guished by antibodies that identify differential expression
of cell surface antigens. However, the molecular and cell
biology studies that defined these populations have
largely been carried out in “bulk” assays, which will fail
to detect cellular subfractions. Indeed, recent studies of
human hematopoiesis have questioned this classical
view of lineage development, raising the possibility
that human hematopoietic progenitor populations are
composed of heterogeneous and lineage-restricted
subpopulations [3].
Advances in single-cell techniques, in particular tran-
scriptional profiling and associated computational strat-
egies, now allow for a more complete investigation of the
cellular heterogeneity that may exist within populations
[4–7]. For example, in the murine hematopoietic system,
single-cell approaches have identified cells transcription-
ally primed towards different fates within the myeloid pro-
genitor population while rare, megakaryocyte-primed
multipotent progenitor cells that arise directly from HSC
and can bypass the MEP in stress or emergency megakar-
yopoiesis have been demonstrated both in mice and zebra-
fish [8–12]. These studies demonstrate the power of
single-cell gene expression techniques to challenge the
conventional models of hematopoiesis by uncovering het-
erogeneity within phenotypically defined cell populations.
Accordingly, a better understanding of the cellular hier-
archy underlying the differentiation of bipotent MEP to
erythroid and megakaryocyte lineage-committed progeni-
tors (EP/MKP) is required. Although several immunophe-
notyping approaches have been proposed to enrich for
human MEP [13–15], under the two best validated strat-
egies, MEP are negatively defined and distinguished from
CMP and GMP by the absence of the surface antigens
CD123 [13] or Flt3/CD135 [15]. This results in a hetero-
geneous population enriched for lineage-biased or com-
mitted megakaryocyte and erythroid progenitors/
precursors with variable contamination with myeloid pro-
genitors [14, 16–18]. Consistent with this, erythroid-
primed MEP and committed EP were recently identified
within the immunophenotypic MEP compartment by their
differential expression of the surface antigens CD71 and
CD105 [17, 18]. This raises the possibility that analogous
megakaryocyte-primed MEP and MKP may also exist
within this population, similar to those characterized in
the murine system [19, 20], although this has yet to be
demonstrated.
The ability to map transcriptional and functional profiles
with cell surface protein expression at the single-cell level
enables a more detailed examination of the homogeneity of
a population than was previously possible [21–23]. In this
report, we illustrate the power of this approach by applying
combined transcriptional, phenotypic, and functional
single-cell analyses to detect and validate novel subpopula-
tions within classically defined, immunophenotypic lineage
(Lin)- CD34 + CD38 + CD123- CD45RA- MEP (Fig. 1).
We first performed targeted expression profiling of 87
genes in 681 single human MEP cells isolated using index
fluorescence-activated cell sorting (FACS). Integrating indi-
vidual cell surface immunophenotype and transcriptional
profiles with functional output in novel, single-cell
differentiation assays revealed that the Lin- CD34 + CD38
+ CD123- CD45RA- “MEP” population in fact comprises
three distinct subpopulations: (1) “Pre-MEP/CMP,”
enriched for bipotent erythroid/megakaryocyte progenitors
with residual myeloid differentiation capacity; (2) “E-MEP,”
which are strongly biased towards erythroid differentiation;
and (3) “MK-MEP,” a less frequent population of bipotent
cells that primarily generate megakaryocytic progeny. Our
study elucidates a novel cellular hierarchy in megakaryo-
cyte/erythroid lineage commitment and an immunopheno-
typing strategy to enable prospective identification of
specific populations, thereby enabling in-depth study of
clinically important disorders of erythro-megakaryopoiesis,
including inherited cytopenias, myeloproliferative disor-
ders, and erythromegakaryocytic leukemias.
Results and discussion
Single-cell gene expression analysis reveals heterogeneity
within phenotypically defined human MEP
To isolate MEP, we adapted a previously validated immu-
nophenotyping strategy in which MEP are distinguished
from the other lineage-negative (Lin-) CD34 + CD38+
hematopoietic progenitors, CMP and GMP, by the ab-
sence of CD123 and CD45RA (Fig. 2a, Additional file 1:
Figure S1A) [24]. To test the hypothesis that cellular het-
erogeneity exists within the MEP compartment, including
cells primed for megakaryocyte versus erythroid differenti-
ation, we analyzed 489 Lin- CD34 + CD38 + CD123-
CD45RA- human MEP cells from three healthy donors.
Individual cells were isolated by index FACS sorting using
a panel of nine cell surface markers (Additional file 1:
Figure S1A). Single-cell gene expression profiling was per-
formed by multiplex RT-PCR using a customized panel of
87 genes, enabling correlation of individual cell surface
immunophenotype and gene expression profiles. This
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gene set included genes predicted to be differentially regu-
lated during erythroid and megakaryocyte differentiation
according to published RNA-Seq datasets from bulk-
sorted, human MEP and mature erythroid and megakar-
yocyte populations [25]; cell surface antigens known to be
expressed during erythroid and megakaryocytic differenti-
ation [8, 25]; and three housekeeping genes. Principal
component analysis (PCA) revealed that MEP were clearly
segregated into two distinct subpopulations by principal
component (PC) 1 (Fig. 2b), which accounted for 10.72 %
of the variance in gene expression between cells (Fig. 2c
and Additional file 1: Figure S1B). No important plate or
sample effect was observed (Additional file 1: Figure
S1C–F).
CD71 and CD41 are early identifiers of erythroid and
megakaryocyte progenitors, respectively [17, 18, 26].
CD42 (glycoprotein 1b) is expressed later during mega-
karyocyte differentiation and has been associated with
unipotent megakaryopoietic activity in mouse models
[26]. These antigens were therefore included in the
immunophenotyping panel used to isolate the original
cells for gene expression profiling and the intensity of
surface expression (mean fluorescence intensity [MFI])
was superimposed on the PCA. This indicated that
the two cellular subsets identified by PCA (Population
1 and 2) were distinguishable by their surface expres-
sion of CD34, CD38, and CD71 (Fig. 2d). Population
1 (left) contained cells with higher CD34 and lower
CD38 expression, suggesting a more immature pheno-
type (Fig. 2d), while Population 2 (right) contained
cells with higher CD71 expression (Fig. 2d). Infre-
quent cells with distinctly higher expression of CD41
and CD42 were notable which did not clearly cluster
with either population by PC1 (Fig. 2e) although the
CD41-high cells separated more distinctly in PCs 3
and 4 (Fig. 2e). We reasoned that these cells might
Fig. 1 Overview of the experimental strategy. CD34+ cells from healthy, mobilized apheresis donors were immunostained with a 10-fluorochrome panel
and single cells were index-sorted into 96-well PCR plates for multiplex qRT-PCR analysis using the Fluidigm Biomark platform. MEP subpopulations were
identified by principal component analysis (PCA) and correlated with the original index sorting data and mRNA levels of surface antigens. Identified
cellular subsets were validated transcriptionally at the population level and functionally in single-cell differentiation assays. Finally, the cells were
ordered in pseudotime to assess differentiation trajectories which were then further validated in functional assays. FACS, fluorescence-activated cell
sorting; IF, immunofluorescence; qRT-PCR, quantitative real-time polymerase chain reaction
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Fig. 2 (See legend on next page.)
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represent megakaryocyte-primed MEP that do not
form a separate cluster on the PCA by PC1 due to
their relatively low frequency.
We next directly analyzed the cell surface expression
of CD71, CD41, and CD42 within Lin- CD34 + CD38 +
CD123- CD45RA- MEP of peripheral blood CD34+ cells
from 14 healthy, G-CSF-treated donors (Fig. 2f, g). In
keeping with the PCA, two subpopulations could be dis-
tinguished by their differential expression of CD71 and a
third by the expression of CD41: (1) CD71-41- (43.6 ±
4.8 % of total MEP); (2) CD71 + 41- (37.4 ± 3.6 %); and
(3) CD71 + 41+, which was significantly less frequent
than the other two populations (5.1 ± 0.6 %, Fig. 2f,
P <0.0001). CD42 expression was restricted to ~1/5
of CD71 + 41 +MEP cells, or ~1 % of total MEP (Fig. 2g).
We then explored the possibility that the CD71 + 41-
and CD71 + 41 +MEP subfractions might represent eryth-
roid and megakaryocyte-primed populations, respectively.
Due to the rarity of the CD71 + 41+ MEP cells, we select-
ively analyzed an additional 192 CD71 + CD41+ MEP cells
from the three same donors by index-FACS sorting for
gene expression profiling. When all 681 analyzable cells
(489 unselected MEP plus 192 71 + 41+ MEP) were stud-
ied, PCA demonstrated that 71 + 41+ MEP constituted a
distinct third population (Fig. 3a), allowing us to identify
three distinct populations on the basis of PCs 1 and 2 for
each individual cell (Fig. 3b). Cells expressing highest
levels of surface CD42 by FACS appeared at the apex of
Population 3 in the PCA (Additional file 1: Figure S2A).
Depicting the data by non-linear dimensionality reduc-
tion (t-distributed stochastic neighbor embedding, t-SNE)
analysis [27–30] also demonstrated three subpopulations,
supporting the PCA (Additional file 1: Figure S2B). To de-
termine whether gene choice was a strong determinant of
the three subpopulation substructure apparent on PCA
and t-SNE, random subsets of genes were selected to per-
form PCA and the proportion of cells that were congru-
ently assigned to each original population was ascertained
(Additional file 1: Figure S2C). This demonstrated that on
average 75 % of the cells are assigned equivalently with as
few as 25 genes. Furthermore, to confirm that the PCA
was not substantially biased by drop-out events, Zero
Inflated Factor Analysis (ZIFA) was performed (Add-
itional file 1: Figure S2D) [31]. In accordance with
PCA and t-SNE, ZIFA also segregated the MEP cells
into three populations (Additional file 1: Figure S2D).
Identifying the 18 most highly weighted genes in PC1
and PC2 (Fig. 3c) and the heatmap of gene expression
(Fig. 3d, Additional file 1: Figure S2E) revealed that the
segregation of the three populations was driven by dif-
ferential expression of megakaryocyte-associated and
erythroid- associated genes. Hierarchical clustering of
the gene expression profiles also supported the division
of Lin- CD34 + CD38 + CD123- CD45RA- MEP into
three subpopulations (Additional file 1: Figure S2F).
Three MEP subpopulations can be prospectively
identified immunophenotypically by their differential
expression of CD44, CD71, and CD41
To determine whether FACS could be used to identify
the three MEP subpopulations that emerged from PCA
of gene expression, we next determined the mean fluor-
escence intensity of antigens in our FACS panel for the
original cells index-sorted for gene expression profiling
(Fig. 4a). The three subpopulations of MEP identified by
PCA could be distinguished with high sensitivity and
specificity (specificity range of 0.81–0.91; sensitivity
0.67–0.90; Additional file 1: Figure S3A) using a combin-
ation of CD71 and CD41: (1) CD71-41-; (2) CD71 + 41-;
and (3) CD71 + 41+. Further, although all of the single
MEP cells had been sorted from the Lin- CD34 + CD38 +
CD123- MEP gate (Fig. 2a, Additional file 1: Figure S1A),
CD71-41- MEP (Population 1) had relatively higher
CD34, lower CD38, and higher CD123 and CD45RA sur-
face antigen expression (Fig. 4a), suggesting they might be
positioned earlier in the HSC/progenitor hierarchy.
(See figure on previous page.)
Fig. 2 Single-cell gene expression analysis demonstrates significant cellular heterogeneity and the presence of subpopulations within classically
defined, immunophenotypic MEP. a A previously validated strategy was used to distinguish MEP from the other lineage-negative (Lin-) CD34+
CD38+ myeloid progenitor populations—common myeloid (CMP) and granulocyte-macrophage progenitors (GMP)—by the absence of CD123
and CD45RA. Quantification gates are shown (sorting gates are shown in Additional file 1: Figure S1A). b Multiplex qPCR of 87 genes in 489 Lin-
CD34 + CD38 + CD123- CD45RA-MEP cells and PCA was performed. The distribution of cells along PC 1 demonstrates two distinct cellular
populations (annotated 1 and 2). c Plot showing % variance by PCs 1–10. d Superimposition of mean log2 fluorescence intensity (MFI) values of
the original cells isolated for qPCR on the PCA for PC1 and PC2 reveals that the two populations have distinct expression profiles for CD34, CD38,
and CD71. e Superimposition of CD41 and CD42 expression on the PCA for PC1 vs. PC2 (MFI, left plots) indicated rare cells with high CD41 and
CD42 expression which did not fall into either Population 1 or 2, suggesting the presence of smaller subpopulation(s) expressing megakaryocyte-
associated antigens. CD41high and CD42high cells segregated more distinctly by PC3 vs. PC4 (relative mRNA expression, right plots). Red-blue scale
indicates high to low expression (customized for each plot in 2D and 2E). f Representative flow plot (left) illustrating differential expression of CD71
and CD41 within immunophenotypic MEP compartment, identifying three subpopulations: (1) CD71-CD41-; (2) CD71 + 41- ; and (3) CD71 + 41+.
Quantification of these three subpopulations (right) in CD34+ cells from 14 healthy donors. Cells falling between FACS gates are excluded from the
chart. CD71 + 41 +MEP are significantly less frequent, constituting 5.1 ± 0.6 % of total MEP (mean ± SEM, P <0.0001). g Expression of CD42 in the three
MEP subfractions. CD42 expression is restricted to a minority (20.7 ± 4.1 %) of CD71 + CD41 +MEP cells (P <0.0001)
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Expression of the early erythroid/megakaryocyte marker
CD36 was lowest in Populations 1 and 3 but did not dis-
criminate clearly between the MEP populations, and
CD42 expression was highest in Population 3 (Fig. 4a).
The cell surface phenotypes showed highly significant cor-
relation with mRNA levels of the same surface proteins
(Additional file 1: Figure S3B). Taken together, these data
indicate that Lin- CD34 + CD38 + CD123- CD45RA-
MEP constitute a heterogeneous population of cells with
at least three distinct subpopulations that can be distin-
guished by unique surface marker and transcript profiles.
Because Population 1 remained negatively defined among
CD34 + 38+ hematopoietic progenitors (Lin- CD34 +
CD38 + CD123- CD45RA-CD71- CD41-), we sought to
A
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Fig. 3 MEP contain three distinct subpopulations segregated by differential expression of megakaryocyte and erythroid-associated genes. a PCA
of 681 cells showing distribution of unselected MEP cells (n = 489; red) and CD71 + 41+ selected MEP (n = 192; blue) for PC 1 (8.95 % variance) and PC2
(5.94 % variance). CD71 + 41+ MEP are distinct from Populations 1 and 2. b The three subpopulations that emerged from the PCA (Fig. 2a) were
defined as Populations 1 (green), 2 (purple), and 3 (orange) on the basis of PC1 and PC2 values. c The 18 most highly weighted genes in PC1 and 2
show that the distinction of the populations is driven by differential expression of key megakaryocyte (orange font) and erythroid-associated (purple
font) genes. Blue font indicates genes associated with more primitive cellular phenotype (CD44 and KIT). Black indicates an MEP gene (DHRS3) and
yellow (GATA1, CD36) genes expressed in both megakaryocytic and erythroid cells. d Heatmap of Ct values shows differential gene expression of 20
selected genes between the three populations identified on the PCA. (Green, Population 1; purple, Population 2; orange, Population 3)
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determine whether our immunophenotyping strategy for
this population could be further refined by including add-
itional surface antigens from our gene expression profiling
panel that were not part of the original FACS panel.
CD44, an adhesion molecule expressed by MEP and early
erythroid and megakaryocytic progenitors that is
downregulated during their differentiation and matur-
ation [32, 33] emerged as the most prominent positive
identifier of Population 1 by gene expression, with a mean
expression level fivefold higher than the other two popula-
tions (P <0.0001, Fig. 4b). Other erythroid/megakaryocytic
surface antigen genes were either barely expressed in
Population 1 (CD61) or were expressed at similar levels in
Populations 1 and 3 (CD9) or in all three populations
(CD105, CD47) (Fig. 4b). MPL expression was detectable
in all three MEP subpopulations, in keeping with previous
reports [14], indicating that MPL is unlikely to be a good
candidate marker to differentiate between the three popu-
lations by immunophenotyping (Fig. 4b).
To confirm the utility of CD44 as a positive identifier of
this population by immunophenotyping, CD44 was incor-
porated into our 10-fluorochrome panel. This allowed us
to separate the MEP population immunophenotypically
into CD44hiCD71- CD41- MEP (Fig. 4c), which had simi-
lar surface CD44 expression to CMP and GMP (Add-
itional file 1: Figure S3C), and CD44modCD71+ MEP,
which contained all of the CD71 + 41- and CD41+ MEP
cells (Fig. 4c). These data confirmed that the differential
expression patterns of CD44, CD71, and CD41 enable
positive identification and prospective isolation of all
three MEP subpopulations. To confirm that the
addition of CD44 to the immunophenotyping panel
defined the transcriptome-identified subpopulations,
100 cells were sorted from each of the three MEP
populations as defined by CD44, CD71, and CD41
co-expression as shown in Fig. 4c, in triplicate from
each of four donors. Multiplex RT-PCR analysis per-
formed using the same panel of gene expression as-
says used for the single-cell transcriptional profiling
confirmed that the cells purified according to this
novel surface phenotype strategy also showed
transcriptional profiles as seen in the original single-
cell analyses (Additional file 1: Figure S3D and 3E).
Differential expression of key megakaryocyte and
erythroid genes between the MEP subpopulations
indicates a “Pre-MEP,” “E-MEP,” and “MK-MEP”
transcriptional profile
Significant differences were observed between these
three populations in the expression of key erythroid and
megakaryocyte genes (Fig. 5a–c). A higher proportion of
cells in Population 1 expressed CSF3R (the granulocyte-
colony stimulating factor [G-CSF] receptor), FLT3/
CD135, and SOCS3 than Populations 2 and 3 and ex-
pression of the key erythroid-megakaryocytic transcrip-
tion factors GATA1 and GATA2 were significantly lower
in this population (Fig. 5a) consistent with a less differ-
entiated state. Expression of myeloperoxidase (MPO), a
gene abundantly expressed by granulocytes, CMP and
GMP [34], was undetectable in all but five of 681 cells in
all three populations (Fig. 5a), confirming that contamin-
ation of the sorted populations with CMP or other mye-
loid cells/progenitors was negligible. Expression of genes
encoding erythroid transcription factors and membrane
proteins, e.g. KLF1, CD71, TMOD1, ANK1, and LEF1
was significantly higher in Population 2 (Figs. 3d and
5b), while Population 3 showed highest expression of
megakaryocyte-associated proteins, including VWF,
FLI1, NFIB, TGFβ, and LOX (Figs. 3d and 5c). Correla-
tions of megakaryocytic (CD9, LOX, MPL, VWF, NFIB,
CD61, TGFβ, FLI1) and erythroid (CD36, KLF1, LEF1,
CNRIP1, TMOD1, MYB) gene sets and megakaryocyte-
erythroid transcription factors (GATA1, GATA2, FOG1)
in all cells suggested co-regulation of same-lineage and
repression of alternate-lineage pathways (Fig. 5d). More-
over, we also found distinct erythroid and megakaryo-
cytic gene co-expression patterns (within the same
single cells) in Population 2 and 3, respectively (Fig. 5e
and 5f). On the basis of these data, we defined Popula-
tion 1 as “pre-MEP/CMP-like” (“Pre-MEP”), Population
2 as erythroid-primed MEP (“E-MEP”), and Population 3
as megakaryocyte-primed MEP (“MK-MEP”).
(See figure on previous page.)
Fig. 4 Cell surface antigen expression discriminates the three MEP subpopulations identified by single-cell gene expression analysis. a Mean
fluorescence intensity (MFI) of eight surface antigens included in the FACS panel for the three populations assigned by PCA. Population 1 (green)
contained cells with significantly higher CD34, CD123, and CD45RA and lowest CD38, CD71, CD41, and CD42 expression. Population 2 (purple)
identified as CD71 + 41- and Population 3 (orange) as CD71 + 41+. b Cell surface antigens included in the qPCR profile panel but not the FACS panel
were considered to further refine the immunophenotyping strategy. CD44 expression emerged from the qPCR data as the most differentially
expressed surface antigen associated with Population 1 (P <0.0001). Star indicators represent significance values (KS test with FDR correction) between
populations: *-q <0.05; **-q <0.01; ***-q <0.001; NS-q >0.05. Data are shown as bee-swarm plots in which the log2 MFI values (a) or relative mRNA
expression level (b) of individual cells are represented as dots with a box plot overlaid. c The utility of CD44 immunophenotyping was validated by flow
cytometry, confirming that high surface expression of CD44 correlates with the CD71- CD41- MEP subfraction. Numbers shown correspond to the
three MEP subsets: Population 1, CD44hi 71- 41- ; population 2, CD71 + 41-; population 3, CD71 + 41+
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Single-cell differentiation assays demonstrate that the
lineage bias suggested by transcriptional and cell surface
profiles correspond to functional differences in lineage
differentiation
To validate that the lineage bias suggested by transcrip-
tional and cell surface profiles corresponded to functional
differences in the ability of the cells to differentiate, we an-
alyzed Pre-MEP, E-MEP, and MK-MEP in single-cell dif-
ferentiation assays. Single cells from the three MEP
populations were seeded by FACS according to the strat-
egy shown in Fig. 4c into conventional colony-forming as-
says in semi-solid medium. Erythroid and myeloid colony-
forming capacity was tested in methylcellulose assays,
which support the growth of erythroid, myeloid, and to a
lesser extent megakaryocytic colonies. Colonies were clas-
sified as myeloid or erythroid by visual inspection (Fig. 6a);
indeterminate colonies were plucked for analysis of
lineage-associated surface antigens by flow cytometry.
There was a marked difference in colony output from the
three MEP populations that matched their transcriptional
profile (Fig. 6a). Over 90 % of colonies arising from single
CD71 + 41- E-MEP cells were erythroid (BFU-E/CFU-E),
compared to ~60 % of colonies arising from single
CD71 + 41+ cells and ~30 % of CD44hi71- 41- MEP col-
onies (P <0.001, Fig. 6a). Wells seeded with CD71 + 41- E-
MEP also had the highest colony-forming efficiency over-
all, with colonies detected in almost 60 % of wells, as com-
pared to ~40 % of wells seeded with CD44hiCD71- 41-
Pre-MEP and ~20 % of wells seeded with CD71 + 41 +
MK-MEP (Additional file 1: Figure S4A). Myeloid colonies
were very rarely observed in wells seeded with E-MEP
and MK-MEP cells, while mixed granulocyte-erythroid-
macrophage-megakaryocyte colonies (CFU-GEMM) and
pure myeloid (granulocyte-macrophage, CFU-GM) col-
onies each constituted 25–30 % of total colonies derived
from Pre-MEP (Fig. 6a). This demonstrated that E-MEP
and MK-MEP were almost exclusively committed to
erythroid-megakaryocytic differentiation. In contrast,
Pre-MEP had maintained potential to generate mye-
loid colonies. Further, Pre-MEP are functionally dis-
tinct from CMP being markedly enriched for erythro/
megakaryopoietic efficiency as compared to CMP
(Additional file 1: Figure S4B), and almost all of the mye-
loid clonogenic output observed in unfractionated MEP is
contained within this fraction. Surface CD44 expression of
cells giving rise to myeloid colonies was significantly
higher than those giving rise to erythroid colonies, con-
firming the utility of CD44 as a positive identifier of cells
with a Pre-MEP phenotype (Additional file 1: Figure S4C).
In contrast, there was no difference in CD123 expression
between cells which gave rise to myeloid colonies versus
those that gave rise to pure erythroid or erythroid/MK
colonies (Additional file 1: Figure S4C).
To test megakaryocyte colony-forming potential, cells
from the three MEP populations were sorted into a
collagen-based medium that supports megakaryocyte
and myeloid colonies (Megacult™). We observed that
MK-MEP cells gave rise to fourfold more megakaryocyte
colonies than the other subpopulations, in keeping with
a megakaryocytic differentiation bias (P <0.001, Fig. 6b).
In semi-solid assays, the growth of either myeloid and
erythroid colonies (methylcellulose) or myeloid and
megakaryocyte colonies (Megacult™) is efficient, but
mixed megakaryocyte-erythroid colonies are infrequent
and single-cell megakaryocyte colony-forming assays are
not possible due to low clonogenic efficiency. Therefore,
to identify bipotent cells with the potential to differenti-
ate into both erythroid and megakaryocytic cells, we uti-
lized a specifically designed single-cell liquid culture
system optimized to support differentiation of erythroid
cells and megakaryocytes. Cells from each MEP fraction
were individually seeded into each well of 96-well plates
containing medium supplemented with the cytokines re-
quired for both erythroid and megakaryocytic differenti-
ation (EPO, TPO, IL3, IL6, SCF) [35, 36]. Wells were
inspected 6 days following seeding by light microscopy
for the presence of characteristic erythroblasts and
proplatelet-forming megakaryocytes (Fig. 6c). The cel-
lular phenotype of the progeny derived from the sin-
gle cells was identified by morphology and the
expression of lineage markers as assessed by fluorescence
microscopy and flow cytometry allowing us to identify
(See figure on previous page.)
Fig. 5 Distinct erythroid-associated and megakaryocyte-associated transcriptional lineage-priming in MEP subpopulations. a Population 1 (green)
contained cells with residual CSF3R, FLT3/CD135, and SOCS3 expression and lowest GATA1 and GATA2 expression, suggesting that this population
comprises progenitors earlier in the hematopoietic hierarchy than populations 2 and 3 and more closely related to CMP. Expression of myeloperoxidase
(MPO) was only detected in five of 681 cells, indicating minimal contamination of the FACS-isolated MEP cells with CMP or other myeloid lineage cells, in
which MPO is strongly positive [20]. b The highest levels of expression of erythroid genes, including KLF1, TMOD1, ANK1, LEF1, and ADD2 were observed
in Population 2 (purple). c The highest levels of expression of megakaryocyte genes, including VWF, FLI1, NFIB, TGFB1, and LOX occurred in Population 3
(orange). Each chart shows a bee-swarm plot where each dot represents the gene expression of an individual cell, with a box plot overlaid. Significance
values are shown for q-values for KS test with FDR correction between populations: *-q <0.05; **-q <0.01; ***-q <0.001; NS-q >0.05. d Heatmap showing
correlation of expression of selected erythroid and megakaryocytic genes within single cells. Color-coding: Orange box, megakaryocyte gene set; purple,
erythroid; yellow, both megakaryocyte and erythroid; green, genes associated with pre-MEP phenotype. e, f Representation of Spearman correlation
coefficient between selected genes in populations 2 (Fig. 5e) and 3 (Fig. 5f), respectively. Blue edges denote positive correlation and red edges denote
negative correlation. Edge thickness is a function of correlation magnitude
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megakaryocyte-only, erythroid-only, and mixed progeny
(Figs. 6d, Additional file 1: Figure S4D).
We used this approach to analyze the three MEP sub-
populations. In this liquid culture system, single E-MEP
cells were significantly more proliferative than the other
two MEP fractions, generating higher numbers of cells 6
days after seeding (Fig. 6e) and had the highest fre-
quency of cells giving rise to populations of exclusively
erythroid progeny (Fig. 6f ). The highest frequency of
pure populations of megakaryocytic cells occurred in
cells seeded with the MK-MEP (Fig. 6f ). Only a minority
of single E-MEP and MK-MEP cells gave rise to “mixed”
colonies containing both erythroid and megakaryocytic
cells (Fig. 6f ). By contrast, mixed colonies occurred in
almost 50 % of wells seeded with cells from the Pre-
MEP fraction (P <0.02, Fig. 6f ), which was also able to
give rise to both unipotent erythroid and unipotent
megakaryocytic cells. Together, these functional data are
consistent with our conclusions from the transcriptional
profiles and support a definition of the cellular subfrac-
tions as: Pre-MEP (CD44hi71- 41-); E-MEP (CD71 + 41-);
and MK-MEP (CD71 + 41+).
Monocle trajectory analysis and sequential cultures
identify a novel megakaryocyte-committed progenitor
population
Finally, we performed a monocle trajectory analysis [37]
to obtain a pseudo-temporal ordering of single cells
along their differentiation trajectory on the basis of
their transcriptional profiles (Fig. 7a, Additional file 1:
Figure S5A, B). Two separate trajectories were inves-
tigated, from Pre-MEP to E-MEP (Fig. 7a, left plot) and
Pre-MEP to MK-MEP (Fig. 7a, right plot). Additional file
1: Figure S5A shows heatmaps illustrating how expression
of selected genes changed with the pseudotime trajector-
ies. Additional file 1: Figure S5B shows selected genes
along the Pre-MEP to E-MEP and MK-MEP trajectories.
This analysis illustrates downregulation of CD44 and
CD34 together with upregulation of GATA1 and CD71
along both trajectories, in keeping with the more primitive
phenotype of the Pre-MEP population, which retains mye-
loid potential. In contrast, a number of genes showed dis-
tinct erythroid or megakaryocyte-specific expression with
progressive separation along each trajectory. For example,
upregulation of CNRIP1, KLF1, and LEF1 occurred along
the E-MEP trajectory and CD41, CD61, CD42, NF1B, and
VWF along the MK-MEP trajectory (Additional file 1:
Figure S5A, B). Notably, CD42 and VWF expression in-
creased markedly along the MK-MEP trajectory and cor-
related with loss of erythroid gene expression such as
KLF1 and CNRIP1 (Additional file 1: Figure S5B). As the
CD42-positive cells also clustered at the apex of Popula-
tion 3 in the PCA (Additional file 1: Figure S2A), we rea-
soned that CD42 surface expression might represent a
marker of full commitment to the megakaryocyte lineage
with associated loss of erythroid potential. To explore
whether the expression of CD42, restricted to ~20 % of
MK-MEP cells and <1 % of total MEP overall (Fig. 2g) was
associated with definitive commitment to the megakaryo-
cyte lineage, in vitro megakaryocyte liquid cultures were
established from healthy donor Lin-CD34+ cells and
defined megakaryocyte progenitor populations were
isolated from day 4 cultures for secondary subcultures
according to their surface CD71, CD41, and CD42 ex-
pression (Fig. 7b, Populations A, B, and C). In sec-
ondary cultures in TPO-based liquid culture, cell
fractions A (CD71 + CD41- CD42-), B (CD71 +CD41 +
CD42-), and C (CD71 + CD41 + CD42+) showed progres-
sive megakaryocyte maturity by morphology and
CD41CD42 co-expression after 3 and 7 further days of
TPO stimulation (Fig. 7c). If switched to EPO-based
medium and methylcellulose (without TPO) for secondary
culture, Populations A and B gave rise to mature
CD71hi GlyA+ erythroblasts and erythroid colonies, while
(See figure on previous page.)
Fig. 6 Single-cell functional assays confirm erythroid and megakaryocyte differentiation bias of CD71 + 41- MEP and CD71 + 41+ MEP, whereas
CD44hi71- 41- MEP demonstrate a “Pre-MEP” phenotype. a Colony-forming capacity of single MEP cells in methylcellulose, which primarily
supports erythroid and myeloid differentiation. Left graph: colony phenotype as a percentage of total colonies grown. The percentage of
erythroid colonies (BFU-E/CFU-E; red) was significantly higher for CD71 + 41- MEP than the other two populations. CD44hiCD71-41- MEP cells
generated a higher percentage of myeloid colonies (CFU-GEMM/GM; blue) than the CD71+ fractions. Photographs show representative BFU-Es
derived from single CD71 + 41- and CD71 + 41+ cells. Data shown are for 30–60 single cells sorted from each population in each of seven
separate experiments. b Megakaryocyte colony-forming potential was tested in a collagen-based assay supporting megakaryocyte and myeloid
but not erythroid colonies. CD71 + 41+ MEP cells gave rise to significantly more megakaryocyte colonies (green; n = 4). c Typical cell cultures 6
days after seeding of single cells from MEP subsets into a liquid culture system supporting erythroid and megakaryocytic differentiation. An
example of a mixed megakaryocyte and erythroid colony is shown for CD71 + 41+ MEP, with two large, proplatelet-forming megakaryocytes
(green stars) and several smaller erythroblasts (red arrow). The example colonies shown for CD44hiCD71- CD41- and CD71 + CD41- MEP are
exclusively erythroid, with a higher proliferation rate in the CD71 + 41- colony. d The identity of cells in individual culture wells was determined
by immunofluorescence (IF) microscopy, flow cytometry, and morphology. Example IF images of mixed (Mix, top), megakaryocyte-only (MK,
middle), and erythroid-only (Ery, bottom) cultures. Cells immunostained for CD71 (FITC, green) and CD41(APC, red). e Cell number in each well 6
days after seeding with a single cell. CD71 + 41- MEP are most proliferative. N = 3. f Summary FACS data for 100 single-cell colonies analyzed
(n = 3). CD44hiCD71- 41-MEP most frequently generated mixed erythroid/megakaryocyte colonies; CD71 + 41- showed mostly erythroid-only and
CD71 + 41+ showed primarily MK-only progeny. P values are for one-way ANOVA between populations
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Population C had no erythroid potential (Fig. 7c, right
panel). This confirmed that both CD71 + 41- 42- and
CD71 + 41 + 42- populations (Populations A and B,
Fig. 7b) contained cells with both megakaryocytic and
erythroid potential, while CD71mid41 + 42+ co-expression
marked the first identifiable lineage-committed MKP with
complete loss of erythroid potential (Population C, Fig. 7b).
In keeping with this, CD71 + 41 + CD42+ cells, compared
to CD71 + 41 + CD42- cells, demonstrated significantly
higher expression of megakaryocyte genes (e.g. CD41,
CD61, VWF, CLU, NF1B) and significantly lower expres-
sion of erythroid-associated genes (e.g. ANK1, CD71,
MYB). MYB is a transcription factor that enhances eryth-
roid differentiation at the expense of megakaryopoiesis
[38], in keeping with commitment to the megakaryocyte
lineage.
Conclusions
To date, the primary intermediate pathway in physio-
logical human megakaryocyte and erythroid differenti-
ation, the MEP, has yet to be well defined. In this study we
applied single-cell approaches to investigate cellular het-
erogeneity among classically defined, immunophenotypic
MEP in order to refine the cellular pathways leading to
megakaryocyte and erythroid lineage commitment.
Single-cell transcriptional profiling of individual MEP
cells with a known immunophenotypic profile demon-
strated that the CD123-CD45RA- fraction of normal
Lin-CD34 + CD38+ cells, previously classified as MEP,
does not constitute a homogeneous population of pro-
genitors. Rather, it is composed of at least three subfrac-
tions with distinct gene expression and functional
capacities—cells enriched for erythroid/megakaryocytic
output but with residual myeloid differentiation capacity
(“Pre-MEP”), and erythroid-primed and megakaryocyte-
primed, bipotent fractions (“E-MEP” and “MK-MEP”)
(model, Fig. 7e). Further, considering the relative proportion
of these cellular fractions (Fig. 2f) and their differentiation
and proliferation efficiencies, we conclude that: (1) only a
minority of classically defined MEP cells (~20 %) are truly
bipotent cells with the capacity for megakaryocyte and
erythroid differentiation as identified by in vitro assays; ra-
ther, the vast majority of single MEP cells preferentially
generate colonies of exclusively erythroid or megakaryo-
cytic progeny; and (2) there is an overall bias towards
erythroid-only output from single MEP cells, as would be
predicted by the observed frequencies of lineage-
committed erythroid and megakaryocytic cells in normal
bone marrow.
This work also demonstrates the power of integrating
data from single-cell gene expression profiling and
single-cell functional assays together with index sorting
data to accurately map the cell surface immunopheno-
type of each individual sorted cell. As illustrated here,
analysis of single-cell gene expression data using higher-
level ordination techniques such as PCA may fail to
identify less-frequent cellular subpopulations, that are
nevertheless clearly distinct when selectively purified
and analyzed in larger numbers.
Our findings are in keeping with recent insights from
single-cell profiling of hematopoietic progenitor cells in-
dicating that a large fraction of these cells are strongly
biased towards specific lineage differentiation pathways ra-
ther than being multi/oligo-potent cells as suggested in the
traditional hematopoietic hierarchical model [3, 7, 39, 40].
In addition, previous studies of murine bone marrow have
demonstrated the existence of megakaryocyte-biased oligo-
potent megakaryocyte/erythroid progenitors [41] and
multipotent progenitors [12, 42], as well as CD71 +
CD105- erythroid-primed MEP in human samples
[18]. However, this is the first report identifying human,
megakaryocyte-biased, bipotent cells and suggesting a
(See figure on previous page.)
Fig. 7 Monocle trajectory analysis and sequential cultures identify a novel megakaryocyte-committed progenitor population. a Pseudo-temporal
ordering of cells using Monocle [37]. Trajectories are shown for Population 1 to 2 (Pre-MEP to E-MEP; left plot) and Population 1 to 3 (Pre-MEP to
MK-MEP; right plot). b CD71 + 41- 42- (Population A), CD71 + 41 + 42- (Population B), and CD71midCD41hiCD42+ (Population C) were FACS-isolated
from day 4 in vitro megakaryocyte cultures for secondary culture and re-plated in either TPO-based (no EPO, left) or EPO-based (no TPO, right)
cultures. c Left: 3 and 7 days after re-plating in TPO medium, Populations A, B, and C demonstrated progressive megakaryocytic maturity. Population A
gave rise to CD41 + CD42-/+ megakaryocytes; b and c showed progressive CD42 acquisition supporting a unidirectional differentiation hierarchy.
Photographs show representative cell cytospins 3 days after secondary culture. Population A shows early megakaryoblasts; Population B shows CD41+
CD42+/- megakaryocytes with single/bi-lobulated nuclei; Population C shows mature, proplatelet-forming megakaryocytes, multilobulated nuclei.
Right: In parallel, Populations A, B, and C were re-plated into EPO-based secondary cultures (without TPO) and methylcellulose to test erythropoietic
potential. A and B gave rise to CD71 + GlyA+ progeny with typical erythroblast morphology and BFU-Es; C were unable to differentiate into erythroid
cells and were immunophenotypically/morphologically identifiable as CD41 + 42+ polyploid megakaryocytes (with abnormal nuclear lobe separation).
n = 4. d Expression of selected genes in the MK-MEP subpopulation stratified according to CD42 cell surface expression. CD71 + 41 + CD42+ cells
showed significantly lower expression of erythroid genes (e.g. ANK1, CD71, MYB), genes associated with more primitive HSC/progenitors (e.g. CD34, CD44)
and higher expression of megakaryocyte genes (e.g. VWF, CD61, CLU, NF1B) than CD71 + 41 + CD42- cells. e A revised model of the megakaryocyte-
erythroid differentiation hierarchy showing replacement of classically defined MEP with three novel subpopulations (yellow box). Arrows represent
weighted differentiation capability; dashed arrows represent the potential for alternate-lineage differentiation. CLP, common lymphoid progenitors;
CMP, common myeloid progenitors; E, erythroid; GMP, granulocyte/macrophage progenitors; HSC, hematopoietic stem cells; LMPP, lymphoid-primed
multipotent progenitors; MEP, megakaryocyte-erythroid progenitors; MK, megakaryocyte; MPP, multipotent progenitors
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strategy for prospective isolation of all three MEP subpop-
ulations and early lineage-committed MKP. Our studies
were performed on samples from healthy apheresis do-
nors who had received treatment to mobilize HSC/
progenitors from the bone marrow to peripheral blood.
As mobilization therapy does not alter the relative propor-
tion of immunophenotypic MEP within the CD34+ cell
compartment [43], we do not anticipate that this will im-
pact on how generalizable our findings will be to other
physiological hematopoietic progenitor populations, but
this will nevertheless be an important factor consider
when applying this novel cell-sorting approach in future
studies of MEP. While our study provides insights into the
heterogeneity of human MEP using a panel of selected
genes, advances in whole transcriptome analysis now
allow unbiased analysis of the transcriptome of single cells.
Such studies might provide additional insights into novel
regulatory pathways and deterministic factors that might
govern erythroid versus megakaryocyte commitment.
These observations redefine the cellular hierarchy
underlying erythroid and megakaryocyte lineage com-
mitment, and will enable a more precise molecular
investigation of normal and perturbed erythro-
megakaryocyte differentiation, such as in myeloprolifera-
tive neoplasms where a pathognomonic increase in
megakaryocyte progenitors occurs, often coupled with
marked anemia, and in erythro-myeloid leukemias. This
work may also assist in strategies aimed at developing
expanded erythroid and megakaryocyte/platelet popula-
tions as cellular therapy.
Methods
Sample preparation
CD34+ cells were collected by apheresis from 14 healthy
donors treated with G-CSF to mobilize hematopoietic
stem/progenitor cells from bone marrow to peripheral
blood. These samples were obtained from the National In-
stitutes of Health Cell Processing Laboratory and the Stem
Cell Laboratory, Hammersmith Hospital, Imperial College
NHS Trust UK. Cryopreserved aliquots of CD34+ cells
were thawed, washed in RPMI + 10 % FBS, and transferred
to PBS + 2 mM EDTA+ 1 % FBS. The mean age of the do-
nors was 45 years (range, 23–68 years); 11/14 were male.
There were no significant differences in the proportion of
MEP as a % of Lin- CD34 + CD38+ cells nor of the MEP
subpopulations between male and female donors, or be-
tween donors younger and older than 45 years of age.
Flow cytometric analysis and sorting
A panel of nine fluorophore-conjugated monoclonal
antibodies plus a live/dead stain was used for flow cy-
tometric cell sorting and analysis as follows: CD34-PE
Cy7 clone 4H11 (eBiosciences); CD38 Alexa Fluor 700
clone HIT2 (eBiosciences); Lineage-APC (containing
antibodies against: CD2, CD3, CD14, CD16, CD19, CD56,
and CD235a, eBiosciences); CD123-BV605 clone 73G (BD
Biosciences); CD45RA-APC eFluor 780 clone HI100
(eBiosciences); CD71-FITC clone OKT9 (eBiosciences);
CD41-efluor 450 clone HIP8 (eBiosciences); CD42-PE
clone HIP1 (eBiosciences) and CD36 PerCP-Cy5.5 clone
CB38 (BD Biosciences). When CD44 was included in the
immunophenotyping panel, CD36 PerCP-Cy5.5 was re-
placed with CD44 PerCP-Cy5.5 clone IM7 (eBiosciences).
Cells were stained with specific antibodies for 20 min
at 4 °C, and washed prior to staining with Live/Dead Fix-
able Aqua Dead Stain Kit (Life Technologies) for 30 min
at room temperature. Cells were washed and analyzed on
a FACSAria III (BD Biosciences) using FACSDIVA™ soft-
ware v. 8.0.1. Gates were set using strict fluorescence-
minus-one controls run for each sample and experiment.
Cell doublets, non-viable (AQUA positive), and lineage-
positive cells were excluded. Data were analyzed on
FlowJo software v. 9.8.2 (Tree Star).
Multiplex, single-cell high throughput microfluidic real-
time PCR
A total of 807 single cells were directly isolated from
three healthy apheresis donors (199 MEP cells plus 70
CD71 + 41+ MEP from each donor). Cells were isolated
by index-FACS into each well of 96-well PCR plates con-
taining 5 μL lysis buffer (CellsDirect One-Step qRT-PCR
kit [Invitrogen], SUPERASE-In RNase inhibitor [Ambion],
TE buffer) and 0.2× Taqman assay mastermix. Plates were
sealed, vortexed, briefly centrifuged and then cDNA syn-
thesis and sequence-specific preamplification performed
(reverse transcriptase – 50 °C, 15 min; inactivation at
95 °C, 2 min; specific target amplification 95 °C 15 s
then 60 °C 4 min, 22 cycles). Plates were stored at –
20 °C until analysis. Preamplified products were diluted
fourfold prior to analysis. Samples were analyzed using
Universal PCR Master Mix (Applied Biosystems) and indi-
vidual Taqman gene expression assays (Life Technologies,
Additional file 2: Table S1), on the Biomark System
(Fluidigm) using the 96.96 Dynamic Arrays as per manu-
facturers protocol. Data were analyzed using Fluidigm RT-
PCR Analysis Software to standardize thresholds for each
gene assay across plates.
The assays were validated by titration to confirm lin-
earity. Eight fourfold serial dilutions were made from
three pools of bulk-sorted cells with technical triplicates
at each dilution. Missing values and those with Ct >40
were removed and technical replicates were subse-
quently merged. Normalization of individual pools was
performed by using a linear model with the formula
Ct.value ~ 0 + dilution + pool to estimate and remove the
effect of the different starting concentrations. Log2(dilution)
was plotted against Ct value and linear models were fitted
for each assay to obtain a coefficient of dilution variable
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and r2 measure of goodness of fit. The model formula was
Ct.value ~ dilution. These analyses showed that all assays
in the panel demonstrated good linearity (Additional
file 2: Table S1).
To validate that the addition of CD44 to the immuno-
phenotyping panel identified the same MEP subpopula-
tions as seen on PCA of the single-cell data, 100 cells
from the three MEP subpopulations (CD44hi CD71- 41-,
CD71 + CD41-, and CD71 + CD41+) were sorted accord-
ing to the strategy in Fig. 4c into wells of a 96-well PCR
plate in triplicate from each of four donors. Cell lysis,
preamplification, and gene expression profiling was then
performed as described above for the single cells (with a
reduction in preamplification cycles from 22 to 16).
Missing values and Ct > 40 were removed and technical
replicates merged. Normalization was performed to the
mean of B2M and GAPDH (as per the single-cell ana-
lysis). Boxplots were prepared in R. P values were gener-
ated using two-sample two-sided T-test.
qRT-PCR data analysis
Data analysis was performed in R (version 3.2.2). Ct
values of all assays marked as “Fail” by the instrument
were set to the limit of detection value (Ct = 40). Ct
values beyond the limit of detection were set to that
value. Non-informative assays with standard deviation of
zero were excluded (n = 3). Some gene assays were in-
cluded in duplicate for quality control; data from these
genes were merged or removed, resulting in data for 87
gene expression assays being included in the analyses
(Additional file 1: Figure S1B). For duplicated assays
where one duplicate failed, data were not merged and
only one replicate kept. For duplicated assays where
good correlation was observed between duplicates, the
data were merged. Gene assays not included in duplicate
were removed if zero variance or the expected distribu-
tion of Ct values was not seen.
Cells were excluded if more than 70 assays did not result
in amplification in that cell. Cells that displayed low levels
of B2M or GAPDH were excluded, using cutoffs of 13 and
15 Ct cycles, respectively. The cutoff values were selected
after inspection of individual histogram plots to identify
outliers. Finally, the mean Ct for each cell was calculated
including Ct values for all assays that yielded detectable
amplification, and cells that displayed mean Ct value
greater than 20 were removed after visual inspection of the
data to exclude outliers. After applying these stringent
technical exclusion criteria, 681 cells were included in ana-
lyses (489 unfractionated MEP cells and 192 71 + 41+ MEP
cells). Ct values were normalized to the mean of B2M and
GAPDH expression. Normalized Ct values and raw data
are listed in Additional file 2: Table S2 and S3, respectively.
PCAs were performed in R using the prcomp function.
Spearman correlation coefficients were calculated in R.
Monocle trajectory analysis was performed using the
monocle R package (version 1.2.0) [37]. 2-(Normalized Ct)
expression values were used for the analysis and house-
keeper genes were excluded. Network visualization of
gene correlation was performed in Cytoscape (version
3.2.1) [44]. t-SNE analysis [27–30] was performed on the
normalized Ct Values in MATLAB (version R2015a).
Data availability
The raw data have been deposited in Gene Expression
Omnibus under accession number GSE79331 and are
provided in Additional file 2: Table S3.
Robustness of PCA clustering by gene permutation
In order to assess the sensitivity of the PCA to gene per-
mutation, the stability of cell-to-cluster assignment was
assessed for subsets of the assayed genes of cardinality
10 to 87. For each gene set size, up to 10,000 distinct
subsets of genes (or fewer where 10,000 distinct permu-
tations were not possible) were selected and PCA was
repeated. Cells were assigned to one of three clusters
using k-means clustering on the basis of the first two PC
values. Correspondence of the clusters defined by k-means
clustering to the clusters defined in Fig. 3b was determined
by obtaining the mode of the original cluster assignments
in each new cluster. The percent of cells assigned to the
same cluster as in the original analysis was then assessed.
Furthermore, for each permutation a random assignment
of cells to clusters was performed and congruency of the
assignments to this cell population was also assessed in
order to evaluate the correct assignment due to chance.
ZIFA analysis
Visualization of the expression data was performed using
the ZIFA tool [31] which accounts for and models the
drop-outs in single-cell analyses. ZIFA requires that the
input drop-out values are represented by values close to
0. Normalized Ct values were transformed so as to sat-
isfy this requirement. The maximal non-drop-out Ct
value per gene was identified (Ctmax_gene) and all drop-
out values were set to two cycles beyond this gene-
specific limit of detection. A transformation inverting
the [0,Ctmax_gene] interval for each gene indvidually was
then applied to the Ct values before the data were used
as input for ZIFA. This ensured that all drop-outs were
correctly treated by ZIFA.
Clonogenic assays in semi-solid medium
Clonogenic assays were performed on FACS-isolated cells
using Methocult H4034 to support erythroid and myeloid
colonies and Megacult to examine megakaryocyte/myeloid
colony formation (both Stemcell Technologies). To assess
erythroid/myeloid colony forming capacity, single cells
were directly sorted into individual wells of flat-bottomed
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96-well plates containing 100 μL Methocult, briefly centri-
fuged, and incubated at 37 °C in a fully humidified 5 %
CO2 atmosphere. Colonies were scored and photographed
using an inverted microscope (Zeiss Axio Observer) at
days 7 and 10–14, as per established criteria [45]. Eryth-
roid colonies were easily identified by their red color and
“burst” morphology (Fig. 6a) and megakaryocyte and mye-
loid colonies by their characteristic size and morphology
[46]. Some individual colonies were plucked from the
semi-solid medium under direct light microscopy on days
12–14, washed, and analyzed by flow cytometry for ex-
pression of lineage-associated surface antigens. Erythroid
cells were identified as CD71 +GlyA+; myeloid as CD11b/
CD14+; and megakaryocytic as CD41 + CD42+. Single-cell
Megacult assays are not possible because of the lower clo-
nogenicity associated with megakaryocyte colony forma-
tion. Therefore, to determine megakaryocyte colony-
forming capacity, MEP subfractions were FACS-isolated
as bulk preparations into 1.5-mL tubes containing 50 μL
Iscove’s Modified Dulbecco’s Medium with 1 % Pen-Strep
and 40 μg/mL human LDL (Stemcell Technologies) and
plated in Megacult medium+ collagen as per manufac-
turer’s protocol in double chamber slides, and incubated
at 37 °C, 5 % CO2 for 8–10 days. Megakaryocyte colonies
were enumerated after fixing and staining with anti-
human GPIIb/IIIa (Stemcell Technologies Megacult stain-
ing kit for CFU-MK) and counterstained with Evans Blue.
Using this method, megakaryocyte and myeloid (GEMM/
GM) colonies are easily distinguished by their pink and
blue stains, respectively. Colony number per 1000 cells
sorted/chamber was calculated.
Single-cell liquid culture assay
Single cells were seeded by index-FACS into individual
wells of round-bottomed 96 well plates containing 70 μL
of serum-free media containing the appropriate cytokines
to support erythroid (EPO, SCF, IL3, IL6) [17, 25, 47] and
megakaryocyte (TPO, SCF, hLDL) [48] differentiation.
Stemspan (Stemcell Technologies) was supplemented
with these cytokines at the following conentrations:
TPO (100 ng/mL); SCF (100 ng/mL); IL3 (10 ng/mL);
IL6 (10 ng/mL); hLDL (40 mg/mL); 1 U/mL EPO. All
cytokines were from Peprotech; hLDL was from
Stemcell Technologies. Wells were inspected by light
microscopy 6 days after seeding and photographed
using a Zeiss Axio Observer microscope to determine
cell number and morphology to identify the presence
of characteristic erythroblasts and proplatelet-forming
megakaryocytes (Fig. 6c). At this time point, MEP-
derived MKP undergo pro-platelet formation, but
minimal apoptosis, and have acquired high levels of
surface CD41 and CD42 allowing their distinction
immunophenotypically from EP which are CD71hi
CD42 negative (Additional file 1: Figure S4D).
For lineage determination by flow cytometry, cells
were immunostained directly in the well to assess sur-
face expression of lineage markers. To analyze wells by
flow cytometry, 40 μL media was carefully removed from
the top of each well, and 20 μL FACS buffer containing
a cocktail of antibodies was added to each well (CD71-
FITC; CD41-PeCy7; CD36 PerCPCy5.5; CD42-PE; GlyA-
Pacific Blue; CD11b/CD14-APC). Plates were incubated
for 20 min at 4 °C, cells washed and analyzed on a LSR
cytometer either manually in microeppendorf tubes placed
inside 5 mL FACS tubes or the entire plate analyzed using
an automated high-throughput sampler. Erythroid cells
were identified as CD71hi CD36hi CD41- CD42- ; mega-
karyocytes identified as CD71mid CD36mid CD41+ 42+;
and myeloid cells as CD11b/CD14+ (no myeloid cells
observed).
To analyze wells by fluorescence microscopy, single
cells were seeded into individual wells of 384-well
Optical Bottom Plates (Nunc) containing 70 μL bipotent
differentiation medium as described above. After 6 days
of incubation, 40 μL media was carefully removed and
20 μL buffer containing CD71-FITC and CD41-APC was
added. Plates were incubated for 20 min at 4 °C, centri-
fuged briefly, and then imaged on a Zeiss Spinning Disk
Confocal microscope.
Determining the differentiation potential of in vitro
cultured megakaryocyte progenitor subsets in sequential
assays
CD34+ cells from mobilized, healthy donors were plated in
Stemspan (Stemcell Technologies) at 1–5×104 cells/mL
with 1 % pen-strep and 10 μL/mL megakaryocyte expan-
sion cocktail containing TPO, SCF, IL6, IL9 (Stemcell tech-
nologies), and hLDL. On day 4, MKP subfractions were
FACS-isolated according to their expression of CD71 and
CD41. At this stage, 85–95 % of MKP remain CD34+. A
total of 3000 cells from CD71 + 41- 42-, CD71 + 41 + 42-,
and CD71 + 41 + 42+ subsets were sorted into 1.5-μL tubes
containing Stemspan, centrifuged, and the pellet resus-
pended in either erythroid (EPO, SCF, IL3, IL6) or
megakaryocyte-specific (TPO, SCF, IL6, IL9, hLDL)
medium; single-cell clonogenic assays in Methocult H4034
were performed as described above. An aliquot of cells
from each well was removed for FACS analysis 3, 6, and 10
days after FACS isolation and cultures replenished with
fresh medium.
Cultured cells were cytocentrifuged at 4000 rpm for 5
min onto Superfrost slides, using a Shandon Cytospin 2
(Fisher Scientific) followed by methanol fixation and
staining with May-Grunwald Giemsa.
Other statistical analyses
Data analysis was performed using Excel and Prism 6
software; graphs drawn using Prism. Mean ± SEM are
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presented. Unpaired T-tests or ANOVA were performed
for the FACS data analysis and differentiation assays as
appropriate and as indicated in figure legends. For qRT-
PCR data and index sorting data, P values were calculated
using the non-parametric Kolmogorov-Smirnov (KS) test
and adjusted to q-values using false discovery rate (FDR)
correction to account for multiple testing [49].
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Declaration.
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